Your browser doesn't support javascript.
loading
Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial.
Qin, Xianhui; Shen, Lin; Zhang, Rong; Li, Youbao; Wang, Xiaobin; Wang, Binyan; Jiang, Xiaodong; Jiang, Hua; Lei, Yu; Hou, Fan Fan; Gu, Jin; Huo, Yong.
Afiliación
  • Qin X; National Clinical Research Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing Cancer Hospital, Beijing, China.
  • Zhang R; Medical Imaging and Minimally Invasive Interventional center, Cancer Center of Sun Yat-sen University &State Key Laboratory of Oncology in Southern China, Guangzhou, China.
  • Li Y; National Clinical Research Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang X; Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
  • Wang B; National Clinical Research Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Jiang X; Department of Oncology, First People's Hospital, Lianyungang, China.
  • Jiang H; Department of Oncology, Second People's Hospital, Lianyungang, China.
  • Lei Y; Department of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Hou FF; National Clinical Research Center for Kidney Disease; State Key Laboratory for Organ Failure Research; Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Gu J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Colorectal Surgery, Peking University Cancer Hospital and Institute, Peking-Tsinghua Center for Life Sciences, Beijing, China.
  • Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China.
Int J Cancer ; 141(4): 837-847, 2017 08 15.
Article en En | MEDLINE | ID: mdl-26991917
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enalapril / Metilenotetrahidrofolato Reductasa (NADPH2) / Ácido Fólico / Hipertensión / Neoplasias / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enalapril / Metilenotetrahidrofolato Reductasa (NADPH2) / Ácido Fólico / Hipertensión / Neoplasias / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: China